Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit

Persephone to utilize the Bacteroides technology for the rapid generation of therapeutics from its planned and ongoing biomarker studies, including the ARGONAUT study.

Case report: butyric acid, bifidobacterium and fructooligosaccharides in a young patient with Rhoemheld syndrome

Vegim Zhaku, from Tetovo University Faculty of Medicine, Macedonia, discussed the case of a male patient with palpitations, shortness of breath, epigastric discomfort and flatulence.

Microbial consortia may help fight intestinal infections

The findings of a recent study suggest that microbial consortia such as MET-2 may be effective strategies to keep intestinal pathogens and antibiotic-resistant organisms at bay.

Gut microbes may trigger life-threatening reaction to stem cell transplants

The findings of a recent study uncover how gut microbes may contribute to trigger GVHD, suggesting potential targets for therapies.

Probi® Sensia – New probiotic concept within cognitive health

Cognitive function, Mood, Sleep and Stress – keywords that are addressed in the new clinically supported probiotic solution, Probi® Sensia to be launched by Probi ® at SupplySide West in…

FMT donors: the importance of gut metabolite screening

Sara Deleu, researcher at KU Leuven, talks about the role of gut metabolite, as Butyric acid and other compounds, during the fecal microbiota transplantation.

Clinical Microbiomics A/S and CosmosID Inc. Merge to Create the Global Leader in Microbiome Research Services

The purpose of the new company is to help scientists worldwide understand how the microbiome influences health and well-being– from humans and animals to plants and the environment.

Can vaginal microbiota transfer influence a newborn’s health?

Larger studies with longer follow-ups are needed to assess whether and how VMT influences neurodevelopment.

How gut microbes boost immune responses to cancer immunotherapy

The findings show that bacterial metabolites can sensitize cancer cells to treatment with immunotherapy by boosting the expression of HLA class I molecules.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top